Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

BACKGROUND: European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc’s optimal management. Herein, we describe current treatment modalities and drug survival in a real-life SSc cohort. METHODS: Details on immunosuppressive/antiprolifera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Panopoulos, S., Chatzidionysiou, Κ., Tektonidou, M. G., Bournia, V. K., Drosos, A. A., Liossis, Stamatis-Nick C., Dimitroulas, T., Sakkas, L., Boumpas, D., Voulgari, P. V., Daoussis, D., Thomas, K., Georgiopoulos, G., Vosvotekas, G., Garyfallos, Α., Sidiropoulos, P., Bertsias, G., Vassilopoulos, D., Sfikakis, P. P.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7092571/
https://ncbi.nlm.nih.gov/pubmed/32293545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-2140-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados